BACKGROUND AND PURPOSE: Embolization of arteriovenous malformations (AVMs) is
commonly used to achieve nidal volume reduction before microsurgical resection or …

BACKGROUND AND PURPOSE: Intracranial hemorrhage is the most severe complication
of brain arteriovenous malformation treatment. We report our rate of hemorrhagic …

OBJECTIVE: Embolization is an important therapeutic modality in the multidisciplinary
management of arteriovenous malformations (AVM); however, prior series have reported a …

OBJECTIVE: To stratify the risk of embolization during the treatment of cerebral
arteriovenous malformations (AVMs) by grade and to assess its impact on overall treatment …

BACKGROUND AND PURPOSE: To report the initial experience by using a new liquid
embolic agent (Onyx) for embolization of brain arteriovenous malformations (AVMs) …

OBJECTIVE: The embolic agents currently used for the treatment of AVMs are n-butyl
cyanoacrylate (NBCA) and ethylene-vinyl alcohol copolymer (ONYX). The purpose of this …

BACKGROUND AND PURPOSE: Embolization is an important therapeutic technique in
brain arteriovenous malformations; however, little has been reported on the factors …

Abstract THE PURPOSE OF this article is to report on the safety and effectiveness of brain
arteriovenous malformation (AVM) embolization for two series of patients, of which one was …

Object The goal of this study was to determine the rates of mortality and morbidity associated
with the embolization of arteriovenous malformations (AVMs) of the brain and to analyze the …

BACKGROUND AND PURPOSE: The appropriate choice of embolic materials with respect
to the permanency of obliterated nidi after embolization and complications related to the …